Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide.

Autor: Herskowitz RD; Joslin Diabetes Center, Brigham and Women's Hospital, Boston, Massachusetts., Jackson RA, Soeldner JS, Eisenbarth GS
Jazyk: angličtina
Zdroj: Journal of autoimmunity [J Autoimmun] 1989 Oct; Vol. 2 (5), pp. 733-7.
DOI: 10.1016/s0896-8411(89)80011-3
Databáze: MEDLINE